Drugmakers Step in to Aid COVID-19-Ravaged India

SUGAR LAND--May 3, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Much has been written of the Pharmaceutical Industry's reliance on drug products from both China and India for active pharmaceutical ingredients (APIs) and generics. But with India's COVID-19 caseloads and deaths surging, drugmakers have responded with promises of desperately needed treatments and vaccines.

Companies featured: Gilead Sciences Incorporated (NASDAQ:GILD), Merck & Co. (NYSE:MRK)